Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: Therapeutic implications and challenges. | World J Stem Cells | 2023 | 37342225 | PubTator, text mining | PubMed |
| Multi-functional adaptor SKAP1: regulator of integrin activation, the stop-signal, and the proliferation of T cells. | Front Immunol | 2023 | 37325633 | PubTator, text mining | PubMed |
| Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway. | Aging (Albany NY) | 2023 | 37319316 | PubTator, text mining | PubMed |
| MST4 promotes proliferation, invasion, and metastasis of gastric cancer by enhancing autophagy. | Heliyon | 2023 | 37313160 | PubTator, text mining | PubMed |
| Vanishing Bile Duct Syndrome in a Patient With Recurrent Hodgkin Lymphoma. | J Med Cases | 2023 | 37303969 | PubTator, text mining | PubMed |
| Low MST1/2 and negative LATS1/2 expressions are associated with poor prognosis of colorectal cancers. | Pathol Res Pract | 2023 | 37302275 | PubTator, text mining | PubMed |
| Treponema denticola Has the Potential to Cause Neurodegeneration in the Midbrain via the Periodontal Route of Infection-Narrative Review. | Int J Environ Res Public Health | 2023 | 37297653 | PubTator, text mining | PubMed |
| Genome-Wide Screening in Human Embryonic Stem Cells Highlights the Hippo Signaling Pathway as Granting Synthetic Viability in ATM Deficiency. | Cells | 2023 | 37296624 | PubTator, text mining | PubMed |
| Novel mutations in a second primary gastric cancer in a patient treated for primary colon cancer. | World J Surg Oncol | 2023 | 37287033 | PubTator, text mining | PubMed |
| Functions of MAP3Ks in antiviral immunity. | Immunol Res | 2023 | 37286768 | PubTator, text mining | PubMed |
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine. | EPMA J | 2023 | 37275549 | PubTator, text mining | PubMed |
| Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3/ALOX15 axis. | Cancer Sci | 2023 | 37271497 | PubTator, text mining | PubMed |
| The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity. | Front Oncol | 2023 | 37265795 | PubTator, text mining | PubMed |
| Evaluation of Nanopore Sensor Design Using Electrical and Optical Analyses. | ACS Nano | 2023 | 37261404 | PubTator, text mining | PubMed |
| The relationship between the Hippo signaling pathway and bone metastasis of breast cancer. | Front Oncol | 2023 | 37256184 | PubTator, text mining | PubMed |
| Comprehensive analysis and molecular map of Hippo signaling pathway in lower grade glioma: the perspective toward immune microenvironment and prognosis. | Front Oncol | 2023 | 37251938 | PubTator, text mining | PubMed |
| The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy. | Acta Pharm Sin B | 2023 | 37250161 | PubTator, text mining | PubMed |
| Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells. | Front Physiol | 2023 | 37250123 | PubTator, text mining | PubMed |
| TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma. | Cancer Sci | 2023 | 37248790 | PubTator, text mining | PubMed |
| Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis. | J Biol Chem | 2023 | 37247756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=23